Overview
Polycythemia is a condition characterized by an abnormally high concentration of red blood cells in the bloodstream, which thickens the blood and can impair circulation. It is broadly divided into primary forms, in which the bone marrow overproduces red cells independently of normal regulation, as in polycythemia vera, and secondary forms, in which increased red-cell production is driven by external factors such as chronic low oxygen, high altitude, or excess erythropoietin. Symptoms can include headache, dizziness, fatigue, and an increased risk of clotting, and management depends on the underlying cause. As a focus within hematology and oncology, polycythemia research addresses its molecular basis, complications, and treatment, particularly the myeloproliferative form polycythemia vera. Work relevant to this topic in Hematology and Oncology Research includes a case report of cutaneous toxicity after prolonged hydroxyurea use in polycythemia vera, a computational analysis of an EPAS1 regulatory variant linked to high-altitude sickness and adaptation, and a report on the evolution of JAK2 V617F-negative idiopathic myelofibrosis into Philadelphia-positive chronic myeloid leukemia. This page gathers peer-reviewed, open-access research relevant to the topic.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 4 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · International Journal of Biometeorology
-
J. Grijalva-Avila et al. · 2025 · Metabolites
-
2025 · Metabolites
-
J. Grijalva-Avila et al. · 2020 · International Journal of Food Science and Nutrition
-
2019 · International Journal of Food Sciences and Nutrition
-
N. Buroker · 2017 ·
-
2017 · Biomedical Genetics and Genomics
-
2017 · Fetal Neonatal and Developmental Medicine
A sample of recent works citing this journal's research on Polycythemia, linking to each citing work.